Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Jarrett

Showing results (201-210 of 241) with videos related to

Pageof 25
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2001
Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve)F E Alexander, R F Jarrett, R A Cartwright, et al.
Cancers|November 27, 2021
HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma PatientsGeok Wee Tan, Peijia Jiang, Ilja M Nolte, et al.
British Journal of Haematology|May 10, 2005
Phenotype and frequency of Epstein-Barr virus-infected cells in pretreatment blood samples from patients with Hodgkin lymphomaGulfaraz Khan, Annette Lake, Lesley Shield, et al.
British Journal of Cancer|August 1, 1991
Viral involvement in Hodgkin's disease: detection of clonal type A Epstein-Barr virus genomes in tumour samplesS Gledhill, A Gallagher, D B Jones, et al.
British Journal of Cancer|March 29, 2000
Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agentsF E Alexander, R F Jarrett, D Lawrence, et al.
British Journal of Haematology|February 16, 2008
Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22Marijke Niens, Lydia Visser, Ilja M Nolte, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2006
The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genesMarijke Niens, Anke van den Berg, Arjan Diepstra, et al.
Blood|September 9, 1999
A novel Epstein-Barr virus-like virus, HV(MNE), in a Macaca nemestrina with mycosis fungoidesE D Rivadeneira, M G Ferrari, R F Jarrett, et al.
International Journal of Cancer|February 5, 2015
Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesisPaul C D Johnson, Karen A McAulay, Dorothy Montgomery, et al.
International Journal of Cancer|August 7, 1997
Determination of HLA-A*02 antigen status in Hodgkin's disease and analysis of an HLA-A*02-restricted epitope of the Epstein-Barr virus LMP-2 proteinH Bryden, J MacKenzie, L Andrew, et al.
Pageof 25

Showing results (201-210 of 241) with videos related to

Sort By:
Pageof 25
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2001
Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve)F E Alexander, R F Jarrett, R A Cartwright, et al.
Cancers|November 27, 2021
HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma PatientsGeok Wee Tan, Peijia Jiang, Ilja M Nolte, et al.
British Journal of Haematology|May 10, 2005
Phenotype and frequency of Epstein-Barr virus-infected cells in pretreatment blood samples from patients with Hodgkin lymphomaGulfaraz Khan, Annette Lake, Lesley Shield, et al.
British Journal of Cancer|August 1, 1991
Viral involvement in Hodgkin's disease: detection of clonal type A Epstein-Barr virus genomes in tumour samplesS Gledhill, A Gallagher, D B Jones, et al.
British Journal of Cancer|March 29, 2000
Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agentsF E Alexander, R F Jarrett, D Lawrence, et al.
British Journal of Haematology|February 16, 2008
Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22Marijke Niens, Lydia Visser, Ilja M Nolte, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2006
The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genesMarijke Niens, Anke van den Berg, Arjan Diepstra, et al.
Blood|September 9, 1999
A novel Epstein-Barr virus-like virus, HV(MNE), in a Macaca nemestrina with mycosis fungoidesE D Rivadeneira, M G Ferrari, R F Jarrett, et al.
International Journal of Cancer|February 5, 2015
Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesisPaul C D Johnson, Karen A McAulay, Dorothy Montgomery, et al.
International Journal of Cancer|August 7, 1997
Determination of HLA-A*02 antigen status in Hodgkin's disease and analysis of an HLA-A*02-restricted epitope of the Epstein-Barr virus LMP-2 proteinH Bryden, J MacKenzie, L Andrew, et al.
Pageof 25